Fig. 2From: Comparison of post-authorisation measures from regulatory authorities with additional evidence requirements from the HTA body in Germany – are additional data requirements by the Federal Joint Committee justified?Data type requests by the G-BAa and the EMAb EMA: European Medicines Agency; G-BA: Federal Joint Committee; PAM: post-authorisation measure; RCT: randomised controlled trial; a per appraisal (N = 20); b per PAM (N = 59)Back to article page